Peripheral/Endo

Inquis Medical Launches First Thrombectomy Catheter with Full 360° Directional Aspiration for Pulmonary Embolism

Peripheral/Endo Radiology by 0 comments

MENLO PARK, Calif.–(BUSINESS WIRE)– #AVENTUSThrombectomy–Inquis Medical, a medical device company pioneering advanced treatments for venous thromboembolic disease, today announced the U.S. commercial launch of the latest AVENTUS™ Catheter, designed to provide physicians with 360° sweeping directional aspiration for clot removal within the vasculature. Austin Bourgeois, MD, performed the first-in-human pulmonary embolism (PE) procedure using the new catheter at Huntsville Hospital in Huntsville, Alabama. AVENTUS is

Continue Reading →

XCath Robotics Receives FDA Breakthrough Device Designation for the Iris System for Remote Robotic-Assisted Mechanical Thrombectomy in Acute Ischemic Stroke

Peripheral/Endo Regulatory by 0 comments

HOUSTON–(BUSINESS WIRE)–XCath Robotics, a medical device company advancing endovascular surgical robotics, announced today the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its Iris Surgical Robotic System for remote robotic-assisted mechanical thrombectomy in patients with acute ischemic stroke. The FDA’s Breakthrough Devices Program is designed to support the development of medical devices that have the potential to provide more effective treatment f

Continue Reading →

Innova Vascular Completes Enrollment in Trust IDE Study Evaluating the Laguna Thrombectomy System for Pulmonary Embolism

Peripheral/Endo Regulatory by 0 comments

IRVINE, CA, UNITED STATES, August 31, 2026 /EINPresswire.com/ — Innova Vascular, Inc., a medical technology company developing innovative endovascular solutions for the treatment of vascular thromboembolism, today announced the completion of patient enrollment in the TRUST pivotal Investigational Device Exemption (IDE) clinical study evaluating the safety and effectiveness of the Laguna® Thrombectomy […]

Continue Reading →

Vesalio Announces FDA 510(k) Clearance of pVasc NET, a Next-Generation Peripheral Mechanical Thrombectomy Device with Integrated Distal Filter

Peripheral/Endo Regulatory by 0 comments

New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval. DALLAS, Aug. 13, 2026 /PRNewswire/ — Vesalio, a global leader in vascular intervention, today announced that the U.S. Food and Drug Administration (FDA)…

Continue Reading →

FastWave Medical Gains FDA IDE Approval to Begin Pivotal Trial of Artero™ Peripheral IVL System

Peripheral/Endo Regulatory by 0 comments

The U.S. pivotal study will evaluate FastWave’s electric IVL system in patients with peripheral artery disease. MINNEAPOLIS, Aug. 11, 2026 /PRNewswire/ — FastWave Medical, which is developing next-generation intravascular lithotripsy (IVL) technology, has received FDA approval of its Investigational Device Exemption (IDE) application, which clears the company to begin a U.S. pivotal trial of its ArteroTM electric IVL […]

Continue Reading →
1 2 3 … 147